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Abstract
Objectives: Osteoblasts lay down new bone on implant surfaces. The underlying cellular mecha-
nism and the spatio-temporal mode of action, however, remain unclear. It can be proposed that
growth factors released upon acidification by osteoclasts adsorb to the implant surface and con-
trol the early stages of osseointegration.
Methods: To simulate bone lysis by osteoclasts, titanium discs were exposed to acid bone lysate
(ABL) followed by vigorous washing and seeding of oral fibroblasts. The expression of TGF-β target
genes interleukin 11 (IL11) and NADPH oxidase 4 (NOX4) was evaluated by reverse transcriptase
polymerase chain reaction and IL11 ELISA. TGF-β signaling activation was assessed via Smad2/3
immunofluorescence. The impact of ABL on osteogenic differentiation was determined with murine
ST2 mesenchymal stromal cells.
Results: We report here that ABL-conditioned titanium discs, independent of turned or rough
surface, increased the expression of IL11 and NOX4. This increase was blocked by the TGF-β
receptor 1 antagonist SB431542. Further support for the TGF-β signaling activation came from
the translocation of Smad2/3 into the nucleus of oral fibroblasts. Moreover, titanium discs
exposed to ABL decreased alkaline phosphatase and osteopontin in ST2 cells.
Conclusions: These in vitro findings suggest that titanium can adsorb TGF-β from ABLs. The
data provide a strong impetus for studies on the protein adsorption on implant surfaces in vitro
and in vivo, specifically for growth factors including bone-derived TGF-β during successful and
failed osseointegration.
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1 | INTRODUCTION
Osseointegration of dental implants is a sequential process that is ini-
tiated by drilling the implant bed. The translation of primary mechani-
cal stability into a secondary one is a sequential process initiated by
the catabolic action of osteoclasts resorbing the injured necrotic
bone.1,2 Approximately 1 week after implant placement, the anabolic
action of osteoblasts takes over forming new woven bone on the sur-
face of the previously resorbed pristine bone and also on the surface
of the titanium implant.1,3,4 Woven bone is later replaced by lamellar
bone that undergoes modeling for functional adaptation and
remodeling for renewal upon fatigue damage.5,6 While the later stages
of osseointegration, that represent bone remodeling have been thor-
oughly investigated, the molecular mechanisms supporting the early
stages of osseointegration are only beginning to be investigated.7
Bone formation requires a solid osteoconductive surface and mes-
enchymal cells that later undergo osteogenic differentiation,8 indepen-
dent of whether it is fracture healing,9 graft consolidation,10 or
osseointegration of dental implants.1 Serum components adsorbing to
the implant surface are thought to provide anchorage for mesenchymal
progenitors.11 The role of growth factors and other molecules released
from the bone surface either spontaneously12 or upon the resorptive
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activity of osteoclasts,13 however, is still unknown. Considering that
the rapid loss of primary stability14 is caused by bone-resorbing
osteoclasts,1,2 it is possible that bone-derived growth factors released
by acidification adsorb to the implant surface, thereby causing a cellular
response during early osseointegration.
We have previously reported on acid bone lysate (ABL) containing
transforming growth factor beta (TGF-β)15 refining knowledge from the
1980s.16–19 The concentration of TGF-β1 with around 0.5 ng/mL in
bone lysate is conserved among skeletal areas and gender.16 TGF-β is
released and activated by osteoclasts20–22 and supports migration of
mesenchymal stem cells.13,23 Recombinant TGF-β1 adsorbs to Ti6Al4V
decreasing osteogenic differentiation in vitro24 and adsorbs to TCP-
ceramic coated implants accelerating repair in a dog model.25 However,
ABLs are a complex mixture of proteins that cannot be compared with
recombinant TGF-β.15 Thus, whether or not TGF-β in ABL adsorbs to
titanium implants causing a cellular response in vitro remains elusive.
Bioassays can determine a potential cellular response to implants
exposed to ABL. We previously used oral fibroblasts to detect the
TGF-β activity in supernatants of freshly prepared bone chips,12
enamel matrix derivatives,26 and demineralized bone.27 Moreover, the
adsorption of TGF-β from these preparations to collagen matrices
commonly utilized for guided bone regeneration was determined by
bioassay.28,29 The bioassay was based on whole genome microarray
resulting in a panel of TGF-β target genes including interleukin
11 (IL11), proteoglycan4 (PRG4), and NADPH oxidase 4 (NOX4).30,31
Further support for the activation of TGF-β signaling comes from
phosphorylation and translocation of Smad3 into the nucleus.32
Since ABL prepared by the hydrochloric acid demineralization of
bone chips activates TGF-β signaling15 and that recombinant TGF-β1
adsorbs to titanium alloys24 it was reasonable to suggest that bone-
derived TGF-β binds to the titanium surface triggering a TGF-β
dependent cell response, thereby simulating the early stages of
osseointegration.
2 | MATERIALS AND METHODS
2.1 | ABL and bone-conditioned medium
Bone was obtained from adult pigs within 6 hours postmortem
(Fleischerei Leopold Hödl, Vienna, Austria). Bone chips were har-
vested from the mandible with a bone scraper (Hu-Friedy, Rotterdam,
the Netherlands). Bone chips were washed with serum-free Dulbec-
co's modified Eagle medium (DMEM) supplemented with antibiotics
(Invitrogen Corporation, Carlsbad, California, USA). For ABL prepara-
tion, 5 g of wet bone chips were incubated while being stirred with
50 mL of 0.1 N HCl (10% weight/volume) at room temperature. ABL
was harvested after 16 hours, centrifuged at 1200 RPM (358 g-force)
for 6 minutes and pH neutralized. After another centrifugation at
1200 RPM (358 g-force) for 6 minutes, ABL was filtered sterile using
a 0.2 μm syringe filter (VWR International, Pennsylvania, USA) and
kept frozen at −20C. The stocks were thawed immediately before
each experiment. For bone-conditioned medium (BCM) preparation,
5 g of bone chips were harvested from the mandible and incubated
with 10 mL serum-free culture medium DMEM (50% weight/volume)
supplemented with antibiotics (Invitrogen Corporation). BCM was har-
vested after 24 hours of incubation at 37C in a humidified atmo-
sphere at 5% carbon dioxide. BCM was filtered sterile using a 0.2 μm
syringe filter (VWR International, Pennsylvania, USA) and kept frozen
at −20C. The stocks were thawed immediately before each
experiment.
2.2 | Cell culture
Human gingiva was harvested from extracted wisdom teeth from
patients who had given informed and written consent. An approval was
obtained from the Ethics Committee of the Medical University of Vienna
(EK NR 631/2007), Vienna, Austria. All experiments were performed in
accordance with relevant guidelines and regulations. A total of three
strains of fibroblasts were established by explant cultures and fewer than
10 passages were used for the experiments. ST2 mesenchymal stromal
cells isolated from mouse bone marrow were obtained from RIKEN Cell
Bank (Tsukuba, Japan), and were grown in Alpha-MEM medium supple-
mented with 10% fetal calf serum (FCS; Invitrogen, Zug, Switzerland).
For the differentiation experiments, the medium was supplemented with
50 μL/mL ascorbic acid (Invitrogen, Zug, Switzerland) and 10 mM
β-glycerophosphate (Invitrogen, Zug, Switzerland), as described previ-
ously.12 All cells used here were seeded at a concentration of 30 000
cells/cm2 onto the ABL-coated titanium discs overnight. For all experi-
ments two different titanium surfaces were tested, turned (Ti Gr. 4;
Implacil De Bortoli, São Paulo, Brazil) and rough (TIO2-blasted and acid-
etched; Implacil De Bortoli, São Paulo, Brazil). For coating the titanium
discs, the discs were soaked for 1 hour either in ABL, BCM or serum-free
culture medium and then thoroughly washed three times with
phosphate-buffered saline for 1 minute. The inhibitor for the TGF-β RI
kinase, SB431542 (Calbiochem, Merck, Billerica, Massachusetts, USA)
was used at 10 μM.
2.3 | Cell viability
Titanium discs were exposed to ABL or serum free media for 1 hour
and then washed with phosphate-buffered saline for 1 minute.
Thereafter, gingival fibroblasts were incubated onto the titanium discs
overnight. MTT (3-[4,5-dimethythiazol-2-yl]-2,5-diphenyltetrazolium
bromide; Sigma, St-Louis, MO, USA) solution at a final concentration of
0.5 mg/mL was added to each well of a microtiter plate (CytoOne) for
2 hours at 37C. The medium was removed and formazan crystals were
solubilized with dimethyl sulfoxide. Optical density was measured at
570 nm. Data were expressed as percentage of optical density in the
treatment groups normalized to unstimulated control values. In addi-
tion, cell viability was assessed by a Live-Dead staining kit from Enzo
Life Sciences AG (Lausen, Switzerland).
2.4 | Reverse transcription-PCR and immunoassay
Reverse transcription (RT) was performed with the SensiFAST cDNA
Synthesis Kit (Bioline Reagents Ltd, London, UK). RT-PCR was done
with SensiFAST SYBR Kit using the manufacturer's instructions
(Bioline). Amplification was performed with the StepOnePlus Real-
Time PCR System (Applied Biosystems, Life Technologies, Carlsbad,
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California, USA). Primer sequences are given in Table 1. Relative gene
expression was calculated with the delta delta CT method. Reactions
were run in duplicates. The supernatant was analyzed for IL11 using
an immunoassay according to the manufacturer's instructions (R&D
Systems, Minneapolis, Minnesota, USA).
2.5 | Immunofluorescence
Immunofluorescent analysis was performed on human gingival fibro-
blasts plated onto titanium discs treated with ABL for 1 hour. Cells were
fixed in paraformaldehyde and blocked in 1% BSA and 0.3% Triton in
PBS at room temperature for 1 hour. Cells were subsequently incubated
with Smad2/3 antibody (1:800, D7G7 XP Rabbit mAb #8685, Cell Sig-
naling, Beverly, Massachusetts, USA) overnight at 4C. Alexa Fluor
488 secondary antibody (1:500; Anti-Rabbit, Cell signaling Technology,
USA) was applied for 1 hour. Cells were washed and mounted onto tita-
nium discs. Fluorescent images were captured at 40× using a fluores-
cent microscope (Oxion, Euromex, the Netherlands).
2.6 | Statistical analysis
All experiments were repeated three to five times. Bars show the
mean and standard deviation of the data from all independent
experiments. Statistical analysis was based on Mann-Whitney U test
and Kruskal-Wallis test with Dunn`s multiple comparisons correction.
Analyses were performed using Prism v7 (GraphPad Software, La
Jolla, California, USA). Significance was set at P < 0.05.
3 | RESULTS
3.1 | Cell viability is maintained upon ABL coating of
titanium
To evaluate the impact of ABL coated discs on cell viability, the forma-
tion of formazan was determined. Exposure of titanium discs to ABL
followed by extensive washing with buffered saline did not change
the viability of human gingival fibroblasts on both titanium surfaces,
turned or rough (Figure 1A). Cell viability was further confirmed by
Live-Dead staining demonstrating most notably high living cells
(Figure 1B). These findings indicate that cells seeded onto titanium
discs coated with ABL are viable under the present in vitro model.
3.2 | Cells increase IL11 upon ABL coating of
titanium
We next investigated the cellular response to titanium discs exposed
to ABL followed by vigorous washing with buffered saline. Gingival
fibroblasts were seeded onto titanium discs with turned and rough
surfaces and the expression of the TGF-β target genes IL11 (Figure 2)
and NOX4 (Supporting Information Figure S1) was determined as pre-
viously reported.15 Titanium surfaces upon ABL treatment, irrespec-
tive of their modification, caused a robust gene expression of IL11
(Figure 2A) and NOX4 (Supporting Information Figure S1) in gingival
fibroblasts. The TGF-β receptor I kinase inhibitor SB431542 blocked
the respective increase in gene expression. Similarly, recombinant
TGF-β adsorbed to titanium discs as indicated by the increased IL11
and NOX4 expression (Supporting Information Figure S2). Figure 2B
shows that also at protein level, ABL treatment of turned or rough
titanium discs caused a robust SB431542-dependent IL11 release into
the cell-culture supernatant. These results suggest that ABL holds a
TGF-β activity that adsorbs to titanium discs.
TABLE 1 Primer sequences
Sequence forward Sequence reverse
hGAPDH aag cca cat cgc tca gac ac gcc caa tac gac caa atc c
hNOX4 tct tgg ctt acc tcc gag ga ctc ctg gtt ctc ctg ctt gg
hIL11 gga cag gga agg gtt aaa gg gct cag cac gac cag gac
hBMP2 cag acc acc ggt tgg aga cca ctc gtt tct ggt agt tct tc
hBMP6 aca tgg tca tga gct ttg tga act ctt tgt ggt gtc gct ga
hMMP10 cat acc ctg ggt ttt cct cca a gtc cgc tgc aaa gaa
gta tgt ttt c
hMMP13 tga gag tca tgc caa caa att c cag cca cgc ata gtc
atg tag a
hPAI1 aag gca cct ctg aga act tca ccc agg act agg cag gtg
hCTGF ctc ctg cag gct aga gaa gc gat gca ctt ttt gcc ctt ctt
mGAPDH aac ttt ggc att gtg gaa gg gga tgc agg gat gat gtt ct
mALP aac cca gac aca agc att cc gag aca ttt tcc cgt tca cc
mOP act cca atc gtc cct aca gtc g tga ggt cct cat ctg tgg cat
FIGURE 1 Cell viability is maintained upon acid bone lysate (ABL) coating of titanium. Turned and rough titanium discs were treated with ABL
for 1 hour followed by three vigorous washes with buffered saline. Oral fibroblasts were seeded onto the discs for 24 hours before a A, MTT
assay and B, a live-dead staining was performed. Merged fluorescent images with living cells appearing in green and dead cells in red. Oral
fibroblasts seeded on turned titanium discs displayed a more spindle-shaped morphology in comparison to those seeded on rough discs. N = 4.
Data represent the mean ± standard deviation relative to the control
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3.3 | Cells activate TGF-β-Smad2/3 signaling upon
ABL coating of titanium
To further verify the activation of TGF-β signaling, immunofluorescent
analysis of Smad2/3 nuclear translocation was performed. Fluorescent
images revealed an indistinct signal when cells were seeded onto
untreated titanium discs. However, a clear nuclear staining of Smad2/3
was visible with titanium discs coated with either ABL or recombinant
TGF-β (Figure 3). These findings further support the hypothesis that
ABL-derived TGF-β activity adsorbs to titanium discs.
3.4 | Cells increase IL11 and NOX4 upon BCM
coating of titanium
Inspired by previous research by our group where we showed that
BCM holds a TGF-β activity,12 gingival fibroblasts were seeded onto
titanium discs that were soaked in BCM followed by vigorous washing
with buffered saline. Similar to our findings with ABL, titanium discs
incubated with BCM caused a robust expression of IL11 and NOX4
with no differences between the surfaces (Figure 4). These data sug-
gest that TGF-β activity, also when derived from native bone chips,
adsorbs to titanium discs.
3.5 | Cells increase other genes possibly relevant for
osseointegration upon ABL coating of titanium
We subsequently examined other potential TGF-β target genes that
possibly play a role during osseointegration of dental implants. Tita-
nium surfaces upon ABL coating, regardless of their surface modifi-
cation, significantly increased the expression of BMP2, BMP6,
MMP10, MMP13, CTGF, and PAI-1 (Figure 5). These findings
FIGURE 2 Cells increase IL11 upon acid bone lysate (ABL) coating of titanium. Turned and rough titanium discs were treated with ABL for 1 hour
followed by three vigorous washes with buffered saline. Gingival fibroblasts were seeded onto the ABL coated titanium discs overnight with and
without SB431542, the inhibitor for the TGF-β RI kinase. A, Reverse transcription PCR analysis and B, immunoassays were performed for IL11.
N = 3-5. Data represent the mean ± standard deviation relative to the control of independent experiments. Mann-Whitney U test (A) and
Kruskal-Wallis test with Dunn’s multiple comparisons correction (B) were performed. Significance is indicated by *P < 0.05
FIGURE 3 Acid bone lysate (ABL) activates TGF-β-Smad2/3 signaling in primary oral fibroblasts on titanium surfaces. Immunofluorescent
analysis was performed on human gingival fibroblasts plated onto titanium discs treated with ABL for 1 hour followed by three vigorous washes
with buffered saline. After 24 hours, cells were incubated with Smad2/3 antibody and detected with Alexa Fluor 488 secondary antibody.
Representative immunofluorescence confirmed the translocation of Smad2/3 into the nucleus on titanium discs coated with either ABL or
recombinant TGF-β
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further indicate that titanium discs can adsorb TGF-β activity upon
soaking in ABL, which then increases the expression of genes that
are of potential relevance for the osseointegration of dental
implants, including growth factors and proteases.
3.6 | Cells decrease alkaline phosphatase activity
upon ABL coating of titanium
We next investigated whether, as reported for ABL and BCM, ST2
mesenchymal cells respond to ABL coating of titanium with a
decrease in alkaline phosphatase12,15 and osteopontin. In accordance
with these studies, titanium discs incubated with ABL caused a signifi-
cant decrease of alkaline phosphatase and osteopontin in ST2 cells at
the level of gene expression within 24 hours of incubation (Figure 6).
These findings suggest that ABL caused a transient inhibition of oste-
ogenic differentiation.
4 | DISCUSSION
Osseointegration is based on the fundamental principle that new bone
grows on the surface of implants without a fibrous interface.33 Even
though the clinical success of implant dentistry has developed con-
stantly over more than three decades, the detailed molecular and cel-
lular events leading to osseointegration are only beginning to be
uncovered.7 Early suggestions based on histological images have
coined the term “distance and contact osteogenesis” meaning that
new bone can form on the surface of pristine bone but also on the
surface of dental implants.34 Contact osteogenesis requires osteo-
genic cells to migrate toward the implant surface where they adhere
and initiate the production of osteoid that is later reinforced by min-
erals.34 There is also evidence that serum components adsorbing to
the implant surface enhance a biological activity for the arriving osteo-
genic cells.11 Apart from serum components, bone can release mole-
cules, either passively upon preparation of an implant bed11,31 or via
osteoclasts during bone resorption.13 However, there are currently no
studies showing if native bone-derived growth factors can adsorb to
an implant surface and cause a biological response.
The results of the current study showed that TGF-β activity of
acid-bone lysates15 adsorbs to titanium implant surfaces. This TGF-β
activity was determined by a bioassay showing the expression of the
respective target genes, including IL11 and NOX4, but also BMP2 and
BMP6, both being growth factors relevant for bone regeneration35,36
and MMP10, MMP13, and PAI-1, together regulating the remodeling
of extracellular matrix.37,38 Also, CTGF being among the target genes,
is critically involved in wound healing and in fibrotic pathologies.39,40
Moreover, our results revealed that the binding of ABL activity was
independent of the surface modification suggesting that the advan-
tages of rough surface implants over turned implants41 cannot be
explained by differential TGF-β activity binding. These data suggest
that bone-derived TGF-β activity adsorbs to titanium surfaces pre-
sumably during the first days of osseointegration where bone forma-
tion on the surface of the implants becomes visible.1
If we relate these findings to those of others, recombinant
TGF-β1 adsorbs to Ti6Al4V24 and ceramic-coated implants.25 It is also
FIGURE 4 Cells increase IL11 and NOX4 upon BCM coating of
titanium. Turned and rough titanium discs were treated with BCM for
1 hour followed by three vigorous washes with buffered saline.
Gingival fibroblasts were seeded onto the BCM-coated titanium discs
for 24 hours. Reverse transcription PCR analyses were performed for
IL11 and NOX4. N = 4. Data represent the mean ± standard deviation
relative to the control of independent experiments. Mann-Whitney
U test was performed. Significant changes compared to unstimulated
control discs are indicated by *P < 0.05
FIGURE 5 Target genes possibly relevant for osseointegration upon ABL coating of titanium. Turned (A) and rough (B) titanium discs were
treated with ABL for 1 hour followed by three vigorous washes with buffered saline. Gingival fibroblasts were seeded onto the ABL coated
titanium discs for 16 hours. Reverse transcription PCR analysis was performed for the indicated target genes. N = 4-5. Data represent the
mean ± standard deviation relative to the control of independent experiments. Mann-Whitney U test was performed. Significant changes
compared to unstimulated control discs are indicated by * P < 0.05 and **P < 0.01
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well accepted that bone contains TGF-β,16–19 and we have recently
extended this knowledge by confirming the TGF-β activity for oral
cells.15 This knowledge, however, does not necessarily mean that
TGF-β activity of ABL exclusively binds to titanium and resists exten-
sive washing. Even though bone contains BMPs42,43 and recombinant
BMPs can adsorb to titanium,44,45 we have not detected BMPs in ABL
by proteomic analysis.15 Thus, bone-derived BMPs might adsorb to
titanium but the concentration is below the threshold that causes a
cellular response such as activation of the BMP-target gene ID2 (data
not shown) and the osteogenic differentiation markers alkaline phos-
phatase and osteopontin. Thus, bioassays revealed bone-derived
TGF-β but not BMP activity adsorbing to titanium.
The present findings provide a basis for future research. Consid-
ering that in vivo, TGF-β attracts mesenchymal cells which later
become osteoblasts during bone remodeling46 and that TGF-β sup-
ports the formation of an extracellular collagen-rich matrix but pre-
vents early osteogenic differentiation,47 the binding of TGF-β activity
might be crucial for the early stages of osseointegration and likely also
for graft consolidation. Our study is a first attempt toward this
research direction and several questions remain to be answered. For
example, to what extent can TGF-β released during peri-implant
bone-resorption in vivo contribute to contact osteogenesis and what
is the major cellular response? It is unlikely that the genes we have
selected substantially contribute to osseointegration as they were
selected mainly based on the sensitivity of TGF-β signaling rather than
to control cellular behavior during osseointegration. The present
research raises even further questions.
How can the observations be interpreted with respect to peri-
implantitis, where inflammatory osteolysis causes the release of TGF-β1
from bone? Under the pathological conditions, extensive release of TGF-
β1 from bone but also other sources might contribute to exceeding colla-
gen production and thus fibrosis that could culminate into implant loss–a
hypothesis that remains to be tested. Moreover, the inflammatory envi-
ronment in peri-implantitis is presumably catabolic and suppresses bone
formation.48 Thus, the in vitro setting presented here does not reflect
the pathological situation of peri-implantitis. Also, the role of other
adsorbed proteins than TGF-β have not been covered in the present
study. Our research included serum components, as we have seeded
cells on the ABL-exposed discs in the presence of serum-containing
medium. This in vitro setting, however, does not rule out the distinct
roles of plasma components on osseointegration in vivo, which are repre-
sented by platelet-rich fibrin. In our recent research, we can confirm the
binding of TGF-β activity on titanium discs. If, however, the plasma and
the bone-derived TGF-β activity competes for the binding to titanium,
and if plasma components even inhibit the absorption of bone-derived
TGF-β remains to be determined.
The target cells and their origin are another issue leading to spec-
ulations. Even though the origin of the mesenchymal cells in vivo that
become osteoblasts in contact osteogenesis needs to be determined,
it is likely that they are derived from H-type capillaries that form as
a consequence of angiogenesis.49 According to our observations
that ABL suppresses osteogenic differentiation of ST2 mesenchymal
stromal cells, it is possible that also in vivo, early osteogenic differenti-
ation is delayed until the catabolic translates into an anabolic environ-
ment. Our data showing that the TGF-β activity adsorbed to titanium
fades after 24 hours support this assumption (Supporting Information
Figure 3). Moreover, mesenchymal cells might be one of several
potential TGF-β target cells that are involved in osseointegration.
There is room for research identifying the response of other lineages
such as the monocytes and their differentiation and polarization
toward the inflammatory or resolving phenotypes, or into bone-
resorbing osteoclasts.
With regards to the research methods, there are also limitations
that need to be acknowledged. Firstly, ABL only to some extent simu-
lates the situation after implant insertion as TGF-β activity is also pas-
sively released from injured bone12,50 and osteoclasts not only use
acids, but also proteases such as cathepsin K to digest bone matrix.51
Secondly, it remains a hypothesis whether bone-derived TGF-β
adsorbing to titanium plays a role in early osseointegration and if so,
to what extent? Studies are needed where implants are placed in bone
lacking TGF-β1, or at least where target cells including those of the
mesenchymal lineage lack the corresponding TGF-β receptor.52 More-
over, there are other sources of TGF-β than the bone and their contri-
bution to osseointegration are also a basis for future research. Thirdly,
our finding that surface modification does not affect the cellular
response to ABL in vitro does not necessarily explain the in vivo
FIGURE 6 Cells decrease alkaline phosphatase activity upon ABL coating of titanium at an early stage. Turned and rough titanium discs were
treated with ABL for 1 hour followed by three vigorous washes with buffered saline. ST2 cells were seeded onto the ABL-coated titanium discs
for 24 and 72 hours. Reverse transcription PCR analysis were performed for alkaline phosphate (ALP) and osteopontin (OP). N = 3-4. Data
represent the mean ± standard deviation relative to the control of four independent experiments. Mann-Whitney U test was performed.
Significant changes compared to unstimulated control discs are indicated by *P < 0.05
STRAUSS ET AL. 341
situation. Fourthly, the adsorption kinetic of bone-derived TGF-β
activity under different conditions such as temperature, time and
long-term storage should be determined further. One option would be
that implant surfaces can be modified with the aim to control the
TGF-β binding, in particular because TGF-β might suppress bone for-
mation and contribute to scar formation.53 Fifthly, it is unknown if
implants made from zirconia show a similar affinity for bone-derived
TGF-β activity. Sixth, the question if TGF-β on the titanium surface is
capable to attract mesenchymal cells is a research opportunity. Finally,
it would be interesting to determine the impact of implants coated
with ABL on the early stages of osseointegration in a preclinical study.
Our findings that bone-derived TGF-β activity rapidly adsorbs to
titanium may provide a new piece of the puzzle in our understanding
of the early stages of osseointegration. These in vitro data may be an
inspiration for future research on how bone-derived molecules con-
tribute to the process of osseointegration with the overall clinical goal
to consider these mechanisms in surgical techniques and in the devel-
opment of implant-related biomaterials.
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